Sanofi poaches AstraZeneca scientist as new research head
drugmaker Sanofi has poached one of AstraZeneca’s top scientists to be its new research head in another high-profile departure for the British drugmaker.
Pharmaceuticals, Biotechnology and Life Sciences
drugmaker Sanofi has poached one of AstraZeneca’s top scientists to be its new research head in another high-profile departure for the British drugmaker.
Skyepharma has made an application to the UK Listing Authority (UKLA) and the London Stock Exchange for the listing of 1,100,000…
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that a Phase 3 monotherapy study met its primary endpoint demonstrating that sarilumab…
Sanofi welcomes new Executive Committee member
Sanofi and MSD/Merck in joint vaccines operations in Europe
Premaitha signs distribution agreement with GeNext in Russia
Premaitha Health, the developer of IONA test, has partnered with Leeds Teaching Hospitals NHS Trust to provide a private NIPT…
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has decided to cancel the admission of its ordinary shares to trading…
Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders
One person has been left brain dead and five others have been hospitalised after taking part in a clinical trial in France of an experimental drug made by Portuguese drug company Bial, French Health Minister Marisol Touraine said on Friday.